AB
Ancilia Biosciences, Inc.
SEC filingOther · New York, NY
Amount raised$10.1Msold at filing
Total offering$10.1M
Investors in the raise23count reported to the SEC
FiledApr 6, 2026first sale Feb 13, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
RODOLPHE BARRANGOUExecutive Officer, Director
ALEXANDRA SAKATOSExecutive Officer, Director
DALE PFOSTDirector
VERA SCHROEDERDirector
GURDANE BHUTANIDirector
Executive officers, directors and promoters as listed on the Form D.